AbCellera Biologics Inc. led a series of pandemic-era billion-dollar valuations with an IPO in December 2020 | Rob Kruyt photos
December 2020
AbCellera Biologics Inc. (Nasdaq:ABCL)
What it does: Biotech specializing in human antibody research
Status achieved: Initial public offering
February 2021
Galvanize
What it does: Governance, risk management and compliance software
Status achieved: Acquisition by New York-based Diligent Corp.
March 2021
GeoComply Solutions Inc.
What it does: Geo-fencing software for gaming, entertainment industries
Status achieved: Funding round
Dapper Labs Inc.
What it does: Non-fungible token (NFT) market place
Status achieved: Two 2021 funding rounds
April 2021
Thinkific Inc. (TSX:THNC)
What it does: Online course-creation
→ Continue reading at BIV